Trial reportJournal of cataract and refractive surgery2026
Three-year comparison of two mix-and-match strategies: enhanced monofocal and trifocal vs enhanced monofocal and trifocal EDOF intraocular lenses.
Trial report in Journal of cataract and refractive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparison of visual performance between three enhanced monofocal intraocular lenses under different refractive targets.Japanese journal of ophthalmology · 2026Observational
- Clinical Outcomes of the First Diffractive Trifocal Intraocular Lens: A Literature Review.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Nd:YAG Capsulotomy Rates of Three FineVision Trifocal Intraocular Lens Platform Across Different Platforms: Results from a Multicenter Clinical Registry Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess and compare 3-year visual and subjective outcomes after mix-and-match implantation of enhanced monofocal and trifocal or trifocal extended depth-of-focus (EDOF) intraocular lenses (IOLs).
settingDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
designSingle-center, prospective, clinical trial.
methods50 patients (100 eyes) received bilateral cataract surgery with implantation of the enhanced monofocal Isopure IOL in the dominant eye and either the trifocal Finevision HP or trifocal EDOF Finevision Triumf IOL in the nondominant eye. At the 3-year examination, binocular uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA) and uncorrected near visual acuity (UNVA), binocular defocus curves, halo/glare simulation, Catquest-9SF questionnaire, spectacle dependence, and Nd:YAG rate were evaluated.
results34 patients (68 eyes) were available at the 3-year follow-up examination. In the Isopure-HP group, binocular UDVA, UIVA (80 cm), UIVA (66 cm), and UNVA were -0.04 ± 0.10 (20/20) logMAR, 0.06 ± 0.07 (20/25) logMAR, 0.10 ± 0.08 (20/25) logMAR, and 0.17 ± 0.08 (20/32) logMAR, respectively. Corresponding values in the Isopure-Triumf group were 0.03 ± 0.11 (20/20) logMAR ( P = .08), 0.09 ± 0.10 (20/25) logMAR ( P = .40), 0.12 ± 0.11 (20/25) logMAR ( P = .56), and 0.27 ± 0.07 (20/40) ( P < .001). P values refer to the difference between both groups. Binocular defocus curves showed ≤0.2 logMAR visual acuities up to -3.0 diopters (D) (Isopure-HP) and -2.0 D (Isopure-Triumf). Halo, glare, and Catquest-9SF scores were comparable ( P > .05). Nd:YAG treatment was required in 15 (44%) of Isopure eyes, 2 (13%) of Finevision HP eyes, and 1 (6%) of Finevision Triumf eyes.
conclusionsCombined implantation of enhanced monofocal and trifocal/trifocal EDOF IOLs yields excellent distance and intermediate vision. Near visual acuity and spectacle independence was higher in the Isopure-HP group. Low incidence of photic phenomena and high patient satisfaction highlight the long-term effectiveness of both mix-and-match strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.